Cite

HARVARD Citation

    Nagel, M. et al. (2021). Refractory acquired thrombotic thrombocytopenic purpura treated with caplacizumab in a pediatric patient with systemic lupus erythematosus. Pediatric blood & cancer. 68 (1), p. n/a. [Online]. 
  
Back to record